Suppr超能文献

靶向增强现实引导下经会阴前列腺穿刺活检研究:初步经验

Targeted augmented reality-guided transperineal prostate biopsies study: initial experience.

作者信息

Theivendrampillai Shenthiuiyan, Yang Bob, Little Mark, Blick Christopher

机构信息

Royal Berkshire Hospital, Reading, Berkshire, UK.

Department of Urology, Royal Berkshire Hospital, Craven Road, Reading, Berkshire RG1 5AN, UK.

出版信息

Ther Adv Urol. 2024 Mar 8;16:17562872241232582. doi: 10.1177/17562872241232582. eCollection 2024 Jan-Dec.

Abstract

BACKGROUND

Transperineal biopsy of magnetic resonance imaging (MRI)-detected prostate lesions is now the established technique used in prostate cancer (CaP) diagnostics. Virtual Surgery Intelligence (VSI) Holomedicine by Apoqlar (Hamburg, Germany) is a mixed reality (MR)/augmented reality (AR) software platform that runs on the HoloLens II system (Microsoft, Redford, USA). Multiparametric prostate MRI images were converted into 3D holograms and added into a MR space, enabling visualization of a 3D hologram and image-assisted prostate biopsy.

OBJECTIVE

The Targeted Augmented Reality-GuidEd Transperineal (TARGET) study investigated the feasibility of performing AR-guided prostate biopsies in a MR framework, using the VSI platform in patients with MRI-detected prostate lesions.

METHODS

Ten patients with a clinical suspicion of CaP on MRI (Prostate Imaging-Reporting and Data System, PI-RADS 4/5) were uploaded to the VSI HoloLens system. Two MR/AR-guided prostate biopsies were then acquired using the PrecisionPoint Freehand transperineal biopsy system. Cognitive fusion biopsies were performed as standard of care following the MR/AR-guided prostate biopsies.

RESULTS

All 10 patients successfully underwent MR/AR-guided prostate biopsy after 3D MR images were overlaid on the patient's body. Prostatic tissue was obtained in all MR/AR-guided specimens. Seven patients (70%) had matching histology in both the standard and MR/AR-guided biopsies. The remaining three had ISUP (International Society of Urological Pathology) Grade 2 CaP. There were no immediate complications.

CONCLUSION

We believe this is a world first. The initial feasibility data from the TARGET study demonstrated that an MR/AR-guided prostate biopsy utilizing the VSI Holomedicine system is a viable option in CaP diagnostics. The next stage in development is to combine AR images with real-time needle insertion and to provide further data to formally appraise the sensitivity and specificity of the technique.

摘要

背景

经会阴对磁共振成像(MRI)检测出的前列腺病变进行活检,是目前前列腺癌(CaP)诊断中常用的技术。德国汉堡的Apoqlar公司的虚拟手术智能(VSI)全息医学是一个混合现实(MR)/增强现实(AR)软件平台,运行于HoloLens II系统(美国雷德福德的微软公司)。多参数前列腺MRI图像被转换为3D全息图并添加到MR空间中,从而能够实现3D全息图的可视化以及图像辅助前列腺活检。

目的

靶向增强现实引导经会阴(TARGET)研究调查了在MR框架下,使用VSI平台对MRI检测出前列腺病变的患者进行AR引导前列腺活检的可行性。

方法

10例临床怀疑患有CaP且MRI检查结果为(前列腺影像报告和数据系统,PI-RADS 4/5)的患者被上传至VSI HoloLens系统。然后使用PrecisionPoint徒手经会阴活检系统进行了两次MR/AR引导的前列腺活检。在MR/AR引导的前列腺活检之后,按照标准治疗流程进行了认知融合活检。

结果

在将3D MR图像叠加到患者身体上之后,所有10例患者均成功接受了MR/AR引导的前列腺活检。所有MR/AR引导的标本均获取到了前列腺组织。7例患者(70%)在标准活检和MR/AR引导活检中组织学结果匹配。其余3例为国际泌尿病理学会(ISUP)2级CaP。未出现即刻并发症。

结论

我们认为这是世界首例。TARGET研究的初步可行性数据表明,利用VSI全息医学系统进行MR/AR引导的前列腺活检在CaP诊断中是一种可行的选择。下一阶段的发展是将AR图像与实时针插入相结合,并提供进一步的数据以正式评估该技术的敏感性和特异性。

相似文献

本文引用的文献

1
Artificial intelligence applications in prostate cancer.人工智能在前列腺癌中的应用。
Prostate Cancer Prostatic Dis. 2024 Mar;27(1):37-45. doi: 10.1038/s41391-023-00684-0. Epub 2023 Jun 9.
2

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验